Chinese Research Funds Accounting Act

Bill: 116-hr-8058
Sponsor: full_name: Rep. Stefanik, Elise M. [R-NY-21]
Introduced: 2020-08-14
Policy area: Science, Technology, Communications
Subjects: Asia

China

Congressional oversight

Foreign and international corporations

Government studies and investigations

Research administration and funding

Research and development
Latest action: action_date: 2020-08-14
text: Referred to the House Committee on Science, Space, and Technology.

Summaries:
action_date: 2020-08-14
action_desc: Introduced in House
text: <p><b>Chinese Research Funds Accounting Act</b></p> <p>This bill directs the Government Accountability Office (GAO) to conduct a study on federal funding made available to entities located in China or majority owned or controlled by the Chinese Communist Party for research in the five years prior to enactment of this bill. </p> <p>Not later than 120 days after the enactment of this bill, the GAO shall brief Congress on the data that is available with respect to federal funding made available to such entities for research.</p>

tv_txt: I 116th CONGRESS 2d Session H. R. 8058 IN THE HOUSE OF REPRESENTATIVES August 14, 2020 Ms. Stefanik (for herself and Mr. Gonzalez of Ohio ) introduced the following bill; which was referred to the Committee on Science, Space, and Technology A BILL To direct the Comptroller General of the United States to conduct a study on certain Federal funding made available to entities located in the People’s Republic of China or majority owned or controlled by the Chinese Communist Party, and for other purposes.

1. Short title This Act may be cited as the Chinese Research Funds Accounting Act . 2. Study and report (a) Study The Comptroller General of the United States shall conduct a study on Federal funding made available to covered entities for research during the study period. (b) Matters To be included The study conducted under subsection (a) shall include, to the extent practicable with respect to the study period, an assessment of— (1) the total amount of Federal funding made available to covered entities for research; (2) the total number and types of covered entities to whom such funding was made available; (3) the requirements relating to the awarding, tracking, and monitoring of such funding; (4) any other data available with respect to Federal funding made available to covered entities for research; and (5) other matters the Comptroller General determines appropriate. (c) Briefing on available data Not later than 120 days after the date of enactment of this Act, the Comptroller General shall brief the Committee on Science, Space, and Technology and the Committee on Foreign Affairs of the House of Representatives and the Committee on Commerce, Science, and Transportation and the Committee on Foreign Relations of the Senate on the data that is available with respect to Federal funding made available to covered entities for research. (d) Report Not later than 240 days after the date of enactment of this Act, the Comptroller General shall submit to the congressional committees specified in subsection (c) a report on the findings of the study conducted under subsection (a). (e) Definitions In this section: (1) Covered entity The term covered entity means an entity— (A) located in the People’s Republic of China; or (B) majority owned or controlled by the Chinese Communist Party. (2) Study period The term study period means the 5-year period ending on the date of enactment of this Act.